Onkaido Therapeutics' Merger

Onkaido Therapeutics raised a round of funding on September 14, 2017. Investors include Moderna Therapeutics.

Onkaido Therapeutics, a new venture formed by Moderna, is focused exclusively on the advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug …

Articles about Onkaido Therapeutics' Merger: